177 related articles for article (PubMed ID: 1341072)
1. Roles for transforming growth factor-alpha in gastric physiology and pathophysiology.
Coffey RJ; Romano M; Polk WH; Dempsey PJ
Yale J Biol Med; 1992; 65(6):693-704; discussion 621-3. PubMed ID: 1341072
[TBL] [Abstract][Full Text] [Related]
2. Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice.
Dempsey PJ; Goldenring JR; Soroka CJ; Modlin IM; McClure RW; Lind CD; Ahlquist DA; Pittelkow MR; Lee DC; Sandgren EP
Gastroenterology; 1992 Dec; 103(6):1950-63. PubMed ID: 1451986
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach.
Takagi H; Jhappan C; Sharp R; Merlino G
J Clin Invest; 1992 Sep; 90(3):1161-7. PubMed ID: 1522224
[TBL] [Abstract][Full Text] [Related]
4. Roles for transforming growth factor-alpha in the stomach.
Coffey RJ; Romano M; Goldenring J
J Clin Gastroenterol; 1995; 21 Suppl 1():S36-9. PubMed ID: 8774988
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of transforming growth factor-alpha in normal and diseased human gastric mucosa.
Bluth RF; Carpenter HA; Pittelkow MR; Page DL; Coffey RJ
Hum Pathol; 1995 Dec; 26(12):1333-40. PubMed ID: 8522306
[TBL] [Abstract][Full Text] [Related]
6. Comparison between transforming growth factor alpha and epidermal growth factor in the protection of rat gastric mucosa against drug-induced injury.
Romano M; Kraus ER; Boland CR; Coffey RJ
Ital J Gastroenterol; 1994 Jun; 26(5):223-8. PubMed ID: 7522648
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo.
Romano M; Polk WH; Awad JA; Arteaga CL; Nanney LB; Wargovich MJ; Kraus ER; Boland CR; Coffey RJ
J Clin Invest; 1992 Dec; 90(6):2409-21. PubMed ID: 1281834
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor.
Luetteke NC; Lee DC
Semin Cancer Biol; 1990 Aug; 1(4):265-75. PubMed ID: 2103501
[TBL] [Abstract][Full Text] [Related]
9. Role of vascular endothelial growth factor in protein loss of Ménétrier's disease.
Takeda T; Mitsuyama K; Tsuruta O; Kuboyama S; Kitazaki S; Sata M
Int J Mol Med; 2006 Oct; 18(4):571-6. PubMed ID: 16964406
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-alpha and epidermal growth factor receptor mRNA in the gastric mucosa of portal hypertensive rats.
Hsieh JS; Wang JY; Lin SR; Hsieh TJ; Huang TJ
Hepatogastroenterology; 2003; 50(53):1305-10. PubMed ID: 14571724
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization.
Sasano H; Suzuki T; Shizawa S; Kato K; Nagura H
Mod Pathol; 1994 Sep; 7(7):741-6. PubMed ID: 7824507
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor alpha.
Kumar V; Bustin SA; McKay IA
Cell Biol Int; 1995 May; 19(5):373-88. PubMed ID: 7640654
[TBL] [Abstract][Full Text] [Related]
14. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
15. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha: an oncodevelopmental growth factor.
Salomon DS; Kim N; Saeki T; Ciardiello F
Cancer Cells; 1990 Dec; 2(12):389-97. PubMed ID: 2088454
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effect of transforming growth factor-alpha on gastric epithelial cell migration through proliferation.
Nakajima N; Kuwayama H
J Clin Gastroenterol; 1995; 21 Suppl 1():S45-9. PubMed ID: 8774990
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
Jhappan C; Takayama H; Dickson RB; Merlino G
Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
[TBL] [Abstract][Full Text] [Related]
19. Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury.
Kosone T; Takagi H; Kakizaki S; Sohara N; Horiguchi N; Sato K; Yoneda M; Takeuchi T; Mori M
BMC Gastroenterol; 2006 Aug; 6():22. PubMed ID: 16879752
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]